Ribonucleotide reductase class III, an essential enzyme for the anaerobic growth of Staphylococcus aureus, is a virulence determinant in septic arthritis

Microbial Pathogenesis

Volumn 43, Issue 5-6, 2007, Pages 179-188

  Kirdis, Ebru ^a   Jonsson, Ing Marie ^a   Kubica, Malgorzata ^a,c   Potempa, Jan ^c   Josefsson, Elisabet ^a   Masalha, Mahmud ^b   Foster, Simon J ^b   Tarkowski, Andrzej ^a  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

^b UNIVERSITY OF SHEFFIELD   (United Kingdom)

^c JAGIELLONIAN UNIVERSITY   (Poland)

Author keywords

nrdDG; Ribonucleotide reductase class III; Septic arthritis; Staphylococcus aureus; Virulence

Indexed keywords

RIBONUCLEOTIDE REDUCTASE; RIBONUCLEOTIDE REDUCTASE CLASS III; UNCLASSIFIED DRUG; VIRULENCE FACTOR;

ANAEROBIC METABOLISM; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL ARTHRITIS; BACTERIAL GENE; BACTERIAL GROWTH; BACTERIAL STRAIN; BACTERIAL VIRULENCE; BACTERIUM MUTANT; BONE DESTRUCTION; CARTILAGE DEGENERATION; CONTROLLED STUDY; DISEASE MODEL; DISEASE SEVERITY; ENZYME ACTIVITY; FEMALE; MALE; MOUSE; NONHUMAN; NRDDG GENE; NUCLEOTIDE SEQUENCE; OXYGEN TENSION; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; STAPHYLOCOCCUS AUREUS; SYNOVITIS;

AEROBIOSIS; ANIMALS; ARTHRITIS, INFECTIOUS; GENE EXPRESSION REGULATION, BACTERIAL; GENE EXPRESSION REGULATION, ENZYMOLOGIC; KIDNEY; MICE; RIBONUCLEOTIDE REDUCTASES; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS; VIRULENCE;

BACTERIA (MICROORGANISMS); MUS; STAPHYLOCOCCUS AUREUS;

EID: 34548660164     PISSN: 08824010     EISSN: 10961208     Source Type: Journal    
DOI: 10.1016/j.micpath.2007.05.008     Document Type: Article

References (36)

1. Garcia-De La Torre I. Advances in the management of septic arthritis. Rheum Dis Clin North Am 29 (2003) 61-75
2. Goldenberg D.L., Chisholm P.L., and Rice P.A. Experimental models of bacterial arthritis. A microbiologic and histopathologic characterization of the arthritis after the intraarticular injections of Neisseria gonorrhoeae, Staphylococcus aureus, group A streptococci, and Escherichia coli. J Reumatol 10 (1983) 5-11
3. Tarkowski A. Infectious arthritis. Best Pract Res 20 (2006) 1029-1044
4. Goldenberg D.L., and Cohen A.S. Acute infectious arthritis. A review of patients with nongonococcal joint infections (with emphasis on therapy and prognosis). Am J Med 60 (1976) 369-377
5. Mitchell W.S., Brooks P.M., Stevenson R.D., and Buchanan W.W. Septic arthritis in patients with rheumatoid disease: a still underdiagnosed complication. J Rheumatol 3 (1976) 124-133
6. Franz A., Webster A.D., Furr P.M., and Taylor-Robinson D. Mycoplasmal arthritis in patients with primary immunoglobulin deficiency: clinical features and outcome in 18 patients. Br J Rheumatol 36 (1997) 661-668
7. Payne D., and Tomasz A. The challenge of antibiotic resistant bacterial pathogens: the medical need, the market and prospects for new antimicrobial agents. Curr Opin Microbiol 7 (2004) 435-438
8. Josefsson E., Hartford O., O′Brien L., Patti J.M., and Foster T. Protection against experimental arthritis by vaccination with clumping factor A, a novel virulence determinant. J Infect Dis 184 (2001) 1572-1580
9. Jonsson I.-M., Mazmanian S.K., Schneewind O., Bremell T., and Tarkowski A. The role of Staphylococcus aureus sortase A and sortase B in murine arthritis. Microbes Infect 5 (2003) 775-780
10. Jonsson I.-M., Mazmanian S.K., Schneewind O., Verdrengh M., Bremell T., and Tarkowski A. On the role of Staphylococcus aureus sortase and sortase-catalyzed surface protein anchoring in murine septic arthritis. J Infect Dis 185 (2002) 1417-1424
11. Abdelnour A., Bremell T., and Tarkowski A. Toxic shock syndrome toxin 1 contributes to the arthritogenicity of Staphylococcus aureus. J Infect Dis 170 (1994) 94-99
12. Nilsson I.-M., Verdrengh M., Ulrich R.G., Bavari S., and Tarkowski A. Protection against Staphylococcus aureus sepsis by vaccination with recombinant staphylococcal enterotoxin A devoid of superantigenicity. J Infect Dis 180 (1999) 1370-1373
13. Jordan A., and Reichard P. Ribonucleotide reductases. Annu Rev Biochem 67 (1998) 71-98
14. Pragman A.A., Yarwood J.M., Tripp T.J., and Schlievert P.M. Characterization of virulence factor regulation by SrrAB, a two-component system in Staphylococcus aureus. J Bacteriol 186 (2004) 2430-2438
15. Chan P.F., and Foster S.J. Role of SarA in virulence determinant production and environmental signal transduction in Staphylococcus aureus. J Bacteriol 180 (1998) 6232-6241
16. Ohlsen K., Koller K.P., and Hacker J. Analysis of expression of the alpha-toxin gene (hla) of Staphylococcus aureus by using a chromosomally encoded hla::lacZ gene fusion. Infect Immun 65 (1997) 3606-3614
17. Ross R.A., and Onderdonk A.B. Production of toxic shock syndrome toxin 1 by Staphylococcus aureus requires both oxygen and carbon dioxide. Infect Immun 68 (2000) 5205-5209
18. Yarwood J.M., McCormick J.K., and Schlievert P.M. Identification of a novel two-component regulatory system that acts in global regulation of virulence factors of Staphylococcus aureus. J Bacteriol 183 (2001) 1113-1123
19. Cramton S.E., Ulrich M., Gotz F., and Doring G. Anaerobic conditions induce expression of polysaccharide intercellular adhesin in Staphylococcus aureus and Staphylococcus epidermidis. Infect Immun 69 (2001) 4079-4085
20. Ollagnier S., Mulliez E., Gaillard J., Eliasson R., Fontecave M., and Reichard P. The anaerobic E. coli ribonucleotide reductase. Subunit structure and iron sulfur center. J Biol Chem 271 (1996) 9410-9416
21. 2+ center. J Biol Chem 274 (1999) 31291-31296
22. Masalha M., Borovok I., Schreiber R., Aharonowitz Y., and Cohen G. Analysis of transcription of the Staphylococcus aureus aerobic class Ib and anaerobic class III ribonucleotide reductase genes in response to oxygen. J Bacteriol 183 (2001) 7260-7272
23. Nilsson I.-M., Hartford O., Foster T., and Tarkowski A. Alpha-toxin and gamma-toxin jointly promote Staphylococcus aureus virulence in murine septic arthritis. Infect Immun 67 (1999) 1045-1049
24. Josefsson E., Juuti K., Bokarewa M., and Kuusela P. The surface protein Pls of methicillin-resistant Staphylococcus aureus is a virulence factor in septic arthritis. Infect Immun 73 (2005) 2812-2817
25. Palmqvist N., Foster T., Fitzgerald J.R., Josefsson E., and Tarkowski A. Fibronectin-binding proteins and fibrinogen-binding clumping factors play distinct roles in staphylococcal arthritis and systemic inflammation. J Infect Dis 191 (2005) 791-798
26. Bremell T., Lange S., Yacoub A., Rydén C., and Tarkowski A. Experimental Staphylococcus aureus arthritis in mice. Infect Immun 59 (1991) 2615-2623
27. Eklund H., Uhlin U., Farnegardh M., Logan D.T., and Nordlund P. Structure and function of the radical enzyme ribonucleotide reductase. Prog Biophys Mol Biol 77 (2001) 177-268
28. Leichtweiss H.P., Lubbers D.W., Weiss C., Baumgartl H., and Reschke W. The oxygen supply of the rat kidney: measurements of int4arenal pO2. Pflugers Arch 309 (1969) 328-349
29. Hollander A.P., Corke K.P., Freemont A.J., and Lewis C.E. Expression of hypoxia-inducible factor 1alpha by macrophages in the rheumatoid synovium: implications for targeting of therapeutic genes to the inflamed joint. Arthritis Rheum 44 (2001) 1540-1544
30. Duthie E.S., and Lorenz L.L. Staphylococcal coagulase: mode of action and antigenicity. J Gen Microbiol 6 (1952) 95-107
31. Helle M., Boeije L., and Aarden L. Functional discrimination between interleukin 6 and interleukin 1. Eur J Immunol 18 (1988) 1525-1540
32. Itou T., Collins L.V., Thoren F.B., Dahlgren C., and Karlsson A. Changes in activation states of murine polymorphonuclear leukocytes (PMN) during inflammation: a comparison of bone marrow and peritoneal exudate PMN. Clin Vaccine Immunol 13 (2006) 575-583
33. Voyich J.M., Braughton K.R., Sturdevant D.E., Whitney A.R., Said-Salim B., Porcella S.F., et al. Insights into mechanisms used by Staphylococcus aureus to avoid destruction by human neutrophils. J Immunol 175 (2005) 3907-3919
34. Goerke C., Campana S., Bayer M.G., Doring G., Botzenhart K., and Wolz C. Direct quantitative transcript analysis of the agr regulon of Staphylococcus aureus during human infection in comparison to the expression profile in vitro. Infect Immun 68 (2000) 1304-1311
35. Wolz C., Goerke C., Landmann R., Zimmerli W., and Fluckiger U. Transcription of clumping factor A in attached and unattached Staphylococcus aureus in vitro and during device-related infection. Infect Immun 70 (2002) 2758-2762
36. B in virulence gene expression during device-related infection. Infect Immun 73 (2005) 3415-3421